352 related articles for article (PubMed ID: 12625364)
41. Protease-activated receptors: the role of cell-surface proteolysis in signalling.
Cottrell GS; Coelho AM; Bunnett NW
Essays Biochem; 2002; 38():169-83. PubMed ID: 12463169
[TBL] [Abstract][Full Text] [Related]
42. Proteinase-activated receptor-1 (PAR(1)) and PAR(2) but not PAR(4) mediate contraction in human and guinea-pig gallbladders.
Lee MC; Huang SC
Neurogastroenterol Motil; 2008 Apr; 20(4):385-91. PubMed ID: 18179608
[TBL] [Abstract][Full Text] [Related]
43. Thrombin receptors in vascular smooth muscle cells - function and regulation by vasodilatory prostaglandins.
Schrör K; Bretschneider E; Fischer K; Fischer JW; Pape R; Rauch BH; Rosenkranz AC; Weber AA
Thromb Haemost; 2010 May; 103(5):884-90. PubMed ID: 20143010
[TBL] [Abstract][Full Text] [Related]
44. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
Bunnett NW
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
[TBL] [Abstract][Full Text] [Related]
45. Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder.
Kirkland JG; Cottrell GS; Bunnett NW; Corvera CU
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G335-46. PubMed ID: 17431214
[TBL] [Abstract][Full Text] [Related]
46. Extrapancreatic trypsin-2 cleaves proteinase-activated receptor-2.
Alm AK; Gagnemo-Persson R; Sorsa T; Sundelin J
Biochem Biophys Res Commun; 2000 Aug; 275(1):77-83. PubMed ID: 10944445
[TBL] [Abstract][Full Text] [Related]
47. Protease signaling in tumor progression.
Camerer E
Thromb Res; 2007; 120 Suppl 2():S75-81. PubMed ID: 18023718
[TBL] [Abstract][Full Text] [Related]
48. Protease-activated receptors: protease signaling in the gastrointestinal tract.
Amadesi S; Bunnett N
Curr Opin Pharmacol; 2004 Dec; 4(6):551-6. PubMed ID: 15525542
[TBL] [Abstract][Full Text] [Related]
49. Mesotrypsin, a brain trypsin, activates selectively proteinase-activated receptor-1, but not proteinase-activated receptor-2, in rat astrocytes.
Wang Y; Luo W; Wartmann T; Halangk W; Sahin-Tóth M; Reiser G
J Neurochem; 2006 Nov; 99(3):759-69. PubMed ID: 16903872
[TBL] [Abstract][Full Text] [Related]
50. Protease activated receptors in cardiovascular function and disease.
Barnes JA; Singh S; Gomes AV
Mol Cell Biochem; 2004 Aug; 263(1):227-39. PubMed ID: 27520681
[TBL] [Abstract][Full Text] [Related]
51. G-protein-coupled receptors as signaling targets for antiplatelet therapy.
Smyth SS; Woulfe DS; Weitz JI; Gachet C; Conley PB; Goodman SG; Roe MT; Kuliopulos A; Moliterno DJ; French PA; Steinhubl SR; Becker RC;
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):449-57. PubMed ID: 19023091
[TBL] [Abstract][Full Text] [Related]
52. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases.
Sokolova E; Reiser G
Thromb Haemost; 2008 Oct; 100(4):576-81. PubMed ID: 18841278
[TBL] [Abstract][Full Text] [Related]
53. Evidence that protease-activated receptor-2 mediates trypsin-induced reversal of stellation in cultured rat astrocytes.
Park GH; Ryu JR; Shin CY; Choi MS; Han BH; Kim WK; Kim HC; Ko KH
Neurosci Res; 2006 Jan; 54(1):15-23. PubMed ID: 16256233
[TBL] [Abstract][Full Text] [Related]
54. Cockroach proteases increase IL-8 expression in human bronchial epithelial cells via activation of protease-activated receptor (PAR)-2 and extracellular-signal-regulated kinase.
Page K; Strunk VS; Hershenson MB
J Allergy Clin Immunol; 2003 Dec; 112(6):1112-8. PubMed ID: 14657869
[TBL] [Abstract][Full Text] [Related]
55. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
[TBL] [Abstract][Full Text] [Related]
56. Protease-activated receptor-2 peptides activate neurokinin-1 receptors in the mouse isolated trachea.
Abey HT; Fairlie DP; Moffatt JD; Balzary RW; Cocks TM
J Pharmacol Exp Ther; 2006 May; 317(2):598-605. PubMed ID: 16434565
[TBL] [Abstract][Full Text] [Related]
57. PAR3 is a cofactor for PAR4 activation by thrombin.
Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
[TBL] [Abstract][Full Text] [Related]
58. Early intraplatelet signaling enhances the release of human platelet PAR-1 and -4 amino-terminal peptides in response to thrombin.
Ofosu FA; Dewar L; Song Y; Cedrone AC; Hortelano G; Craven SJ
Biochemistry; 2009 Feb; 48(7):1562-72. PubMed ID: 19182900
[TBL] [Abstract][Full Text] [Related]
59. Proteinases as hormones: targets and mechanisms for proteolytic signaling.
Hansen KK; Oikonomopoulou K; Baruch A; Ramachandran R; Beck P; Diamandis EP; Hollenberg MD
Biol Chem; 2008 Aug; 389(8):971-82. PubMed ID: 18979623
[TBL] [Abstract][Full Text] [Related]
60. Protease-activated receptor 3 is a second thrombin receptor in humans.
Ishihara H; Connolly AJ; Zeng D; Kahn ML; Zheng YW; Timmons C; Tram T; Coughlin SR
Nature; 1997 Apr; 386(6624):502-6. PubMed ID: 9087410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
